TY - CHAP M1 - Book, Section TI - Blood Vessel & Lymphatic Disorders Year in Review A1 - Papadakis, Maxine A. A1 - McPhee, Stephen J. A1 - Rabow, Michael W. A1 - McQuaid, Kenneth R. PY - 2023 T2 - Current Medical Diagnosis & Treatment 2023 AB - Dual treatment with rivaroxaban 2.5 mg orally twice daily and aspirin 81 mg orally daily has been shown to reduce limb-related events, major amputation, and cardiovascular events. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193123458 ER -